EP. 1: Case 1: FLT3+ AML
Watch
EP. 2: Case 1: Allelic Burden in FLT3+ AML
EP. 3: Case 1: Treatment Recommendations for FLT3+ AML
EP. 4: Case 1: Targeted Therapy in FLT3+ AML
EP. 5: Case 2: AML With Myelodysplasia-Related Changes
EP. 6: Case 2: CPX-351 Treatment for AML With MRC
EP. 7: Case 2: Selecting a Targeted Therapy for AML With MRC
EP. 8: Case 2: CPX-351 Trial Data in AML
EP. 9: Case 2: Novel Therapies for AML With MRC
EP. 10: Case 3: IDH2-Mutated AML
EP. 11: Case 3: Targeting IDH in AML
EP. 12: Case 3: IDH Inhibitors for the Treatment of AML
EP. 13: Case 4: High-Risk de novo AML
EP. 14: Case 4: Treating AML With HMA/Venetoclax
EP. 15: Case 4: Observations of HMA/Venetoclax in Trials
EP. 16: Case 4: Additional Considerations in High-Risk de novo AML
